UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Focal therapy will become a standard option for selected men with localized prostate cancer

Journal of clinical oncology, 2014-11, Vol.32 (32), p.3680-3681

2014

Link zum Volltext

Verfügbarkeit prüfen

Active surveillance: is there a need for better risk stratification at the outset?

Journal of clinical oncology, 2010-10, Vol.28 (28), p.e513; author reply e514-e513

2010

Link zum Volltext

Verfügbarkeit prüfen

Circulating chromatin conformation signatures to enhance PSA positive predictive value and overall accuracy for prostate cancer detection

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17016-e17016

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the prevalence and nature of sleep disturbances in prostate cancer patients receiving androgen deprivation therapy using a combination of actigraphy and sleep questionnaires

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e17046-e17046

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative healthcare research outcomes of novel Surgery in prostate cancer (IP4-CHRONOS): Pilot RCT assessing feasibility of randomization for focal therapy in localized prostate cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5086-5086

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Proclarix, a prostate cancer risk score, used together with magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.278-278

2020

Link zum Volltext

Verfügbarkeit prüfen

Late toxicity described using patient reported outcomes measures (PROMS) in men treated with salvage radiation following primary high intensity focal ultrasound (HIFU) for localized prostate cancer

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.131-131

2019

Link zum Volltext

Verfügbarkeit prüfen

Population-based prostate cancer screening using a prospective, blinded, paired screen-positive comparison of PSA and fast MRI: The IP1-PROSTAGRAM study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5513-5513

2020

Link zum Volltext

Verfügbarkeit prüfen

The CADMUS trial: A paired cohort, blinded study comparing multiparametric ultrasound targeted biopsies with multiparametric MRI targeted biopsies in the detection of clinically significant prostate cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5008-5008

2021

Link zum Volltext

Verfügbarkeit prüfen

MRI and targeted biopsies compared to transperineal mapping biopsies for targeted ablation in recurrent prostate cancer after radiotherapy: Primary outcomes of the FORECAST trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5009-5009

2021

Link zum Volltext

Verfügbarkeit prüfen

Is vitamin D deficiency in breast cancer patients associated with aggressive prognosis?

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e12511-e12511

2014

Link zum Volltext

Verfügbarkeit prüfen

Initial experience of the adjuvant treatments to the local tumor for metastatic prostate cancer: Assessment of novel treatment algorithms, a multicenter, phase II randomized controlled trial (IP2-ATLANTA)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS5600-TPS5600

2020

Link zum Volltext

Verfügbarkeit prüfen

Intratumoural (IT) evolutionary landscape of high-risk prostate cancer and outcome: The PROGENY (PROstate cancer GENomic heterogeneitY) study of genomic and immune parameters

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e17500-e17500

2020

Link zum Volltext

Verfügbarkeit prüfen

Oncological outcomes of 356 patients undergoing salvage focal ablative HIFU or cryotherapy following radiation failure

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5582-5582

2020

Link zum Volltext

Verfügbarkeit prüfen

Does focal high-intensity focused ultrasound have a role in treating localized prostate cancer in the elderly?

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.133-133

2015

Link zum Volltext

Verfügbarkeit prüfen

The PROMIS study: A paired-cohort, blinded confirmatory study evaluating the accuracy of multi-parametric MRI and TRUS biopsy in men with an elevated PSA

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5000-5000

2016

Link zum Volltext

Verfügbarkeit prüfen

Multiparametric magnetic resonance imaging in the diagnosis and characterisation of prostate cancer: The PROMIS study

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.62-62

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictors of sorafenib efficacy in treated patients with hepatocellular carcinoma: A tertiary cancer center experience

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15604-e15604

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability and outcomes of immunotherapy in minority underserved population

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15004-e15004

2018

Link zum Volltext

Verfügbarkeit prüfen

Pre-therapy neutrophil-to-lymphocyte ratio and lymphocyte-to-monocyte ratio do not predict survival in patients treated with immune checkpoint inhibitors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15092-e15092

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic score to predict time to castration-resistance in underserved patients with metastatic prostate cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16518-e16518

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost implications of reactive versus prospective testing for dihydropyrimidine dehydrogenase (DPD) deficiency in patients with colorectal cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3627-3627

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

ThemaAdult

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Focal therapy will become a standard option for selected men with localized prostate cancer

Active surveillance: is there a need for better risk stratification at the outset?

Circulating chromatin conformation signatures to enhance PSA positive predictive value and overall accuracy for prostate cancer detection

Evaluating the prevalence and nature of sleep disturbances in prostate cancer patients receiving androgen deprivation therapy using a combination of actigraphy and sleep questionnaires

Comparative healthcare research outcomes of novel Surgery in prostate cancer (IP4-CHRONOS): Pilot RCT assessing feasibility of randomization for focal therapy in localized prostate cancer

Evaluation of Proclarix, a prostate cancer risk score, used together with magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

Late toxicity described using patient reported outcomes measures (PROMS) in men treated with salvage radiation following primary high intensity focal ultrasound (HIFU) for localized prostate cancer

Population-based prostate cancer screening using a prospective, blinded, paired screen-positive comparison of PSA and fast MRI: The IP1-PROSTAGRAM study

The CADMUS trial: A paired cohort, blinded study comparing multiparametric ultrasound targeted biopsies with multiparametric MRI targeted biopsies in the detection of clinically significant prostate cancer

MRI and targeted biopsies compared to transperineal mapping biopsies for targeted ablation in recurrent prostate cancer after radiotherapy: Primary outcomes of the FORECAST trial

Is vitamin D deficiency in breast cancer patients associated with aggressive prognosis?

Initial experience of the adjuvant treatments to the local tumor for metastatic prostate cancer: Assessment of novel treatment algorithms, a multicenter, phase II randomized controlled trial (IP2-ATLANTA)

Intratumoural (IT) evolutionary landscape of high-risk prostate cancer and outcome: The PROGENY (PROstate cancer GENomic heterogeneitY) study of genomic and immune parameters

Oncological outcomes of 356 patients undergoing salvage focal ablative HIFU or cryotherapy following radiation failure

Does focal high-intensity focused ultrasound have a role in treating localized prostate cancer in the elderly?

The PROMIS study: A paired-cohort, blinded confirmatory study evaluating the accuracy of multi-parametric MRI and TRUS biopsy in men with an elevated PSA

Multiparametric magnetic resonance imaging in the diagnosis and characterisation of prostate cancer: The PROMIS study

Predictors of sorafenib efficacy in treated patients with hepatocellular carcinoma: A tertiary cancer center experience

Safety, tolerability and outcomes of immunotherapy in minority underserved population

Pre-therapy neutrophil-to-lymphocyte ratio and lymphocyte-to-monocyte ratio do not predict survival in patients treated with immune checkpoint inhibitors

Prognostic score to predict time to castration-resistance in underserved patients with metastatic prostate cancer

Cost implications of reactive versus prospective testing for dihydropyrimidine dehydrogenase (DPD) deficiency in patients with colorectal cancer

Aktive Filter

Suchergebnisse filtern